Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Most Shorted Stocks
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Investors
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Careers
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
MCP for Agents
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Most Shorted Stocks
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Center
Investors
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
CNTB
Stock Latest News
Market News
3 Penny Stocks on Investors’ Radar, October 1
1d ago
TGE
CNTB
Premium
Market News
Why Is Penny Stock Connect Biopharma (CNTB) Up 98% Today?
2d ago
CNTB
Premium
Company Announcements
Connect Biopharma reports positive Phase 2 COPD results
2d ago
8K
CNTB
Premium
The Fly
Connect Biopharma announces results from global Phase 2 study of rademikibart
2d ago
CNTB
Premium
The Fly
Connect Biopharma price target lowered to $5 from $8 at Oppenheimer
10d ago
CNTB
Premium
Ratings
Buy Rating Maintained on CNTB as Rademikibart Data Supports Upside; $7 Price Target Reiterated
15d ago
CNTB
Premium
The Fly
Connect Biopharma price target lowered to $6 from $7 at Canaccord
16d ago
CNTB
Premium
Company Announcements
Connect Biopharma reports positive Phase 2 asthma results
17d ago
8K
CNTB
Premium
Ratings
CNTB: Buy Rating Reiterated with Unchanged $7 Price Target Ahead of Seabreeze Trial Catalysts
21d ago
CNTB
Premium
The Fly
Connect Biopharma reports Q2 EPS (27c), consensus (31c)
2M ago
CNTB
Premium
The Fly
Connect Biopharma price target raised to $7 from $6 at Canaccord
2M ago
CNTB
Premium
Ratings
Buy Rating Reiterated on CNTB as Clinical Derisking Looms and Risk/Reward Remains Attractive; $10 Price Target Maintained
2M ago
CNTB
Premium
The Fly
Connect Biopharma initiated with an Outperform at Oppenheimer
3M ago
CNTB
Premium
Ratings
Biren Amin Initiates Buy on Rademikibart Developer with Overweight Rating and DCF-Based $7 Price Target on Differentiated Asthma/COPD Opportunity
3M ago
CNTB
Premium
The Fly
Connect Biopharma initiated with an Overweight at Piper Sandler
3M ago
CNTB
Premium
Ratings
Buy Rating Reiterated on Connect Biopharma as Analyst Sees Underappreciated Rademikibart Upside; $7 Price Target Maintained
3M ago
CNTB
Premium
The Fly
Canaccord sees potential Apogee buyout as ‘huge win’ for sector
3M ago
ABBV
APGE
Premium
The Fly
Connect Biopharma initiated with a Buy at Canaccord
4M ago
CNTB
Premium
The Fly
Connect Biopharma initiated with an Overweight at Cantor Fitzgerald
4M ago
CNTB
Premium
The Fly
Connect Biopharma initiated with an Overweight at Cantor Fitzgerald
4M ago
CNTB
Premium
The Fly
Connect Biopharma files to sell 6.13M ordinary shares for holders
5M ago
CNTB
Premium
Ratings
Analyst Reiterates Buy on Rademikibart, Citing Strong Clinical Profile, Large Market Opportunity and Unchanged $10 Price Target
5M ago
CNTB
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
